More patients are using GLP-1 medications such as WeGovy and Mounjaro as part of their type 2 diabetes care or to support weight loss in obesity. We are aware that some of our patients are seeking GLP-1 medications privately, if you are unsure if your private provider has informed us that you are taking the medication - please let us know. It is important we have an up to date record of medication so we can ensure safe prescribing of your other medicines. This is particularly important for women taking oral contraception or oral HRT medications. See our website for more information ⤵️ https://www.priorymedical.com/news/glp-1-medications/ The practice are getting a lot of requests to prescribe Semaglutide (Wegovy), Liraglutide (Saxenda) or Tirzepatide (Mounjaro) for weight loss purposes. While NICE have approved the use of GLP-1 medications for obesity via the NHS recently, this is not available to us in general practice to prescribe. If you have a raised BMI and would like to discuss other options to support you with weight loss do get in touch to arrange a routine appointment. Referral to the specialist tier 3 obesity clinic has specific criteria but locally you can also seek help with obesity and weight loss via the council Health Trainers or Healthwise. More information here ⤵️ https://www.priorymedical.com/referrals-resources/weight-loss-and-exercise/ In October 2025, Humber and North Yorkshire ICB announced the new primary care weight management service to support the prescribing of mounjaro for eligible patients via community pharmacies (not GP practices). Patients can self refer if they fulfil the strict criteria here ⤵️ https://letsgetbetter.co.uk/weight-management/
Park View, Victoria Way and occasionally Lavender Grove surgery will close for an afternoon if staffing pressures or to avoid lone working. See our monthly News Post with more details of specific opening hours.
